Morning Briefing
Summaries of health policy coverage from major news organizations
Johnson & Johnson To Pay $2.2 Billion Fine To Resolve Drug Marketing Case
The government alleged that the drug company and its subsidiaries promoted psychiatric medications for uses that had not been approved by the Food and Drug Administration.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
